Literature DB >> 9021933

Cystic fibrosis transmembrane conductance regulator mediates the cyclic adenosine monophosphate-induced fluid secretion but not the inhibition of resorption in mouse gallbladder epithelium.

R H Peters1, J H van Doorninck, P J French, R Ratcliff, M J Evans, W H Colledge, J Bijman, B J Scholte.   

Abstract

We have studied the physiological role of the cystic fibrosis (CF) gene product (cystic fibrosis transmembrane conductance regulator [CFTR]) in gallbladder epithelium using a knockout mouse model for CF. We found that normal mouse gallbladder epithelium expresses functional CFTR as shown by reverse-transcription polymerase chain reaction (RT-PCR) analysis and Ussing chamber experiments. Gallbladders from Cftr -/- mice were structurally intact as shown by microscopic and physiological parameters but lacked the cyclic adenosine monophosphate (cAMP)-induced chloride current observed in normal gallbladders. In fluid transport measurements, normal and Cftr -/- gallbladders were equally active in basal resorption. The addition of forskolin, which activates CFTR anion channel activity through the cAMP system, resulted in net fluid secretion in normal gallbladders. In contrast, Cftr -/- gallbladders were unable to secrete fluid while a complete inhibition of resorption by forskolin was observed. We conclude that, in normal mouse gallbladder epithelium, cAMP-induced fluid secretion involves simultaneous inhibition of apical sodium chloride resorption and activation of CFTR. Our data support the hypothesis that gallbladder disease in CF is at least in part caused by a deficient secretory response to the endogenous cAMP-linked hormones VIP and secretin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9021933     DOI: 10.1002/hep.510250203

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies.

Authors:  Dominique Debray; Dominique Rainteau; Véronique Barbu; Myriam Rouahi; Haquima El Mourabit; Stéphanie Lerondel; Colette Rey; Lydie Humbert; Dominique Wendum; Charles-Henry Cottart; Paul Dawson; Nicolas Chignard; Chantal Housset
Journal:  Gastroenterology       Date:  2012-02-24       Impact factor: 22.682

2.  Pancreatic and biliary secretion are both altered in cystic fibrosis pigs.

Authors:  Aliye Uc; Radhamma Giriyappa; David K Meyerholz; Michelle Griffin; Lynda S Ostedgaard; Xiao Xiao Tang; Marwa Abu-El-Haija; David A Stoltz; Paula Ludwig; Alejandro Pezzulo; Maisam Abu-El-Haija; Peter Taft; Michael J Welsh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-30       Impact factor: 4.052

3.  Inflammatory cytokines alter human gallbladder epithelial cell absorption/secretion.

Authors:  R V Rege
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

4.  Endothelin-1 is synthesized and inhibits cyclic adenosine monophosphate- dependent anion secretion by an autocrine/paracrine mechanism in gallbladder epithelial cells.

Authors:  L Fouassier; T Chinet; B Robert; A Carayon; P Balladur; M Mergey; A Paul; R Poupon; J Capeau; V Barbu; C Housset
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

5.  Liver X receptor β regulates bile volume and the expression of aquaporins and cystic fibrosis transmembrane conductance regulator in the gallbladder.

Authors:  Nathan Sweed; Hyun-Jin Kim; Kjell Hultenby; Rodrigo Barros; Paoo Parini; Valentina Sancisi; Birgitta Strandvik; Chiara Gabbi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-07-14       Impact factor: 4.871

6.  Early pathogenesis of cystic fibrosis gallbladder disease in a porcine model.

Authors:  Keyan Zarei; Mallory R Stroik; Nick D Gansemer; Andrew L Thurman; Lynda S Ostedgaard; Sarah E Ernst; Ian M Thornell; Linda S Powers; Alejandro A Pezzulo; David K Meyerholz; David A Stoltz
Journal:  Lab Invest       Date:  2020-07-27       Impact factor: 5.502

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.